Losartan Potassium Tablet, Film Coated
Product Images NDC 71335-1102

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 71335-1102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713351102)

Losartan is a potassium tablet which contains 50mg of medication. It comes in a package by Eryant Rench Bunbank with the batch number 04 91500. The tablets should be kept out of reach of children and stored at a temperature of 20-25°C (68°-77°F). The medication can be compared to Cozaar 50mg Tablet. There is a total of 30 tablets in the package, and they should be used before the expiry date. The NDC number is 7133511021, and the UPC code is 042381128689.*

FDA Label Image

Lbl713351580

This is a description of a medication package containing Losartan Potassium 100mg Tablets. The package was packed by Bryane Reanch and is comparable to Cozaar 100mg Tablets by Hetro Labs Lineid. The package contains 30 tablets with an expiration date of MM/YY. The NDC number for the package is 043831138709. The medication should be stored at a room temperature of 20°-25°C (68°-77°F), and kept out of the reach of children.*

FDA Label Image

Lbl713351582

This is a description of a medication containing potassium, in the form of a 25mg tablet. The medication should be stored at room temperature according to the instructions on the package, which was packaged by Eryanc Ranch Bnlauk. The medication is manufactured by HebroLabs Limited and is comparable to Cozaar 25mg Tablet. The package contains 90 tablets, and has an expiration date of MM/YY. The NDC number is 7133515821 045191143351.*

FDA Label Image

Losartanaddress2 (Losartanaddress2)

FDA Label Image

Losartanfigure1 (Losartanfigure1)

FDA Label Image

Losartanfigure2 (Losartanfigure2)

This appears to be a medical study presenting data on adjusted risk reduction for a particular condition. The study reports a risk reduction of 26%, with a confidence value (p) of 0.001. The graph shows the percentage of patients experiencing a specific type of event (likely cardiovascular-related) over the course of several months. However, as the context and additional data is missing, it is impossible to determine the specifics of the condition being studied.*

FDA Label Image

Losartanfigure3 (Losartanfigure3)

The text seems to be a table showing primary endpoint events within different demographic subgroups for two drugs, Losartan and Atanold. The table has columns with sample size and number of events, and rows with different demographic subgroups. There is also a note at the bottom about the symbols being proportional to the sample size.*

FDA Label Image

Losartanfigure4 (Losartanfigure4)

The text describes a percentage value (% patents with event) related to Risk Reduction equal to 18.1%, with an additional value of 0022 and the unit of measure is not specified. The word "Months" is also present although its significance is not clear without additional context.*

FDA Label Image

Losartanstructure (Losartanstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.